Abstract
Serotonin (5-HT) plays a major role in the pathophysiology of primary headaches. The presynaptic 5-HT uptake mechanism, which is important for the regulation of 5-HT levels in the neuronal synapses, can be examined indirectly by measuring the number of 5-HT transporters in membranes from platelets. The aim of the present study was to investigate the platelet 5-HT transport system in patients with primary headache disorders. Bmax, an index of the number of platelet 5-HT transporters, was measured in 40 patients with chronic tension-type headache, in 30 patients with migraine without aura, and in 40 healthy controls using a binding analysis with tritiated paroxetine as the ligand. The Bmax was 664 (589-846) (median (quartiles)) fmol/mg protein in patients with tension-type headache and 662 (534-781) fmol/mg protein in healthy controls, P = 0.40. The Bmax was 675 (558-747) fmol/mg protein in patients with migraine, which was not significantly different from the Bmax in controls, P = 0.94. In conclusion, the present results indicate that the number of platelet 5-HT transporters is normal in patients with chronic tension-type headache and in patients with migraine without aura.Copyright Lippincott-Raven Publishers
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | European Journal of Neurology |
| Vol/bind | 5 |
| Udgave nummer | 3 |
| Sider (fra-til) | 277-282 |
| Antal sider | 6 |
| ISSN | 1351-5101 |
| DOI | |
| Status | Udgivet - maj 1998 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'The platelet serotonin transporter in primary headaches'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS